Allergan manufactures Botox in the United States and is FDA-approved to treat glabellar lines, forehead wrinkles and crow's feet. It has also been recently approved to aid in the treatment of chronic migraines. The iconic brand was the first product of its kind to receive approval from the United States Food and Drug Administration in 2002 for aesthetic use and is honoring this milestone by celebrating its loyal patients and suppliers on the aesthetics of Allergan Aesthetics, an AbbVie company, develops, manufactures and markets a portfolio of leading brands and aesthetic products. Its aesthetic portfolio includes facial injectables, body contouring, plastics, skin care and more.
Its goal is to provide customers around the world with innovation, education, exceptional service and a commitment to excellence, all with a personal touch. We also welcome the opportunity to listen to you on these social channels, but remember that we work in a highly regulated industry with unique legal considerations. Before participating, read and respect our community standards established for each channel. You must be logged in to view this article.
YOU ARE ABOUT TO GO TO A THIRD-PARTY WEBSITE The Yes link below will take you out of the AbbVie family of websites. Links that take you off AbbVie websites around the world are not under the control of AbbVie, and AbbVie is not responsible for the content of such sites or any other links on that site. AbbVie provides these links to you only as a convenience and the inclusion of any link does not imply AbbVie's approval of the linked site. The website you requested may not be optimized for your screen size.
Do you want to leave this site? The scientific, unbranded name for Botox is onabotulinumtoxinA, which is actually one of seven different strains of botulinum toxin that are produced from a bacterium called Clostridium botulinum. Thus, Botox Cosmetic (OnabotulinumtoxinA) was born and created a new category (and phenomenon) in the field of facial aesthetics. Brin was able to share with us that, it starts with the purified raw material of botulinum neurotoxin type A, in which less than one gram of the purified toxin is enough to produce the worldwide supply of Botox and Botox Cosmetic for a whole year. Brin says that Allergan marketed the drug and then acquired Oculinum in 1991, and changed the name to Botox in 1992, but at that time a standard treatment approach for aesthetic use had not been established.
Brin explains that the effects of Botox can spread and cause severe symptoms hours or weeks after the injection. If you're interested in trying Botox or Botox Cosmetic, it's important that you're aware of any risks or side effects. By now you've definitely heard of Botox or Botox Cosmetic, the anti-aging injectable that celebrities made very popular in the early 2000s. Mitchell Brin is the Senior Vice President of Drug Development and the Scientific Director of Botox %26 Neurotoxins at Allergan.
Mitchell Brin, to share what botox is really made of, how it works and exactly what is injected into millions every year.